Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Get Adobe Flash player

Video: OxyContin's phase out Add to ...

Dr. David Juurlink, head of clinical pharmacology and toxicology at Sunnybrook, explains how the OxyNEO compares to OxyContin

More Related to this Story

Follow us on Twitter: @globeandmail